The NF-κB pathway leads to the upregulation of pro-inflammatory genes that, if not controlled at homeostatic levels, can lead to the onset and progression of inflammatory bowel diseases (IBDs) [84,85,86]. The gene discussed is NFKB1; the disease is inflammatory bowel disease.